NasdaqCM - Nasdaq Real Time Price USD
Tiziana Life Sciences Ltd (TLSA)
1.2200
+0.0600
+(5.17%)
As of 12:57:51 PM EDT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-15,698
-15,698
-19,615
-21,762
-11,335
Investing Cash Flow
-1,253
-1,253
-3,996
130
-123
Financing Cash Flow
40
40
-55
-23
75,346
End Cash Position
1,183
1,183
18,122
42,186
65,824
Capital Expenditure
-3
--
--
-22
-3
Issuance of Capital Stock
24
24
--
--
71,157
Issuance of Debt
1,880
--
--
--
163
Repayment of Debt
-119
-119
-55
-152
-277
Free Cash Flow
-15,698
-15,698
-19,615
-21,784
-11,338
12/31/2020 - 11/20/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACUT AccuStem Sciences, Inc.
0.3900
-11.36%
OKYO OKYO Pharma Limited
1.4900
+10.37%
CNTB Connect Biopharma Holdings Limited
0.6700
-1.57%
ANNX Annexon, Inc.
1.8650
+5.97%
NNVC NanoViricides, Inc.
1.3600
+1.52%
VCNX Vaccinex, Inc.
0.7500
+7.14%
PSTV Plus Therapeutics, Inc.
1.0950
+39.14%
MREO Mereo BioPharma Group plc
2.5600
+2.40%
PHIO Phio Pharmaceuticals Corp.
2.0700
-17.53%
ALLR Allarity Therapeutics, Inc.
1.0213
+3.04%